Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil vs Azathioprine in Lupus Nephritis
NCT02949349Phase 2Completed
- Sponsor
- Genovate Biotechnology
- Start
- Jul 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of mycophenolate mofetil in lupus nephritis (LN) (3 arms), sponsored by Genovate Biotechnology. Primary endpoints: Change in serum albumin at 24 weeks, Change in serum creatinine at 24 weeks and 1 more. Started Jul 2015; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT02949349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02949349.